The menopause market in Canada is expected to reach a projected revenue of US$ 784.9 million by 2030. A compound annual growth rate of 0.8% is expected of Canada menopause market from 2025 to 2030.
The Canada menopause market generated a revenue of USD 729.7 million in 2024 and is expected to reach USD 784.9 million by 2030.
The Canada market is expected to grow at a CAGR of 0.8% from 2025 to 2030.
In terms of segment, dietary supplements was the largest revenue generating treatment in 2024.
Hormonal is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
Market revenue in 2024
USD 729.7 million
Market revenue in 2030
USD 784.9 million
Growth rate
0.8% (CAGR from 2025 to 2030)
Largest segment
Dietary supplements
Fastest growing segment
Hormonal
Historical data
2018 - 2023
Base year
2024
Forecast period
2025 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Hormonal, Non-Hormonal, Dietary Supplements
Key market players worldwide
Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis
Other key industry trends
In terms of revenue, Canada accounted for 4.1% of the global menopause market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In North America, U.S. menopause market is projected to lead the regional market in terms of revenue in 2030.
Mexico is the fastest growing regional market in North America and is projected to reach USD 511.0 million by 2030.
There is an increase in awareness about dietary requirements, leading to a greater demand for them among older women. A study was conducted to assess the availability of Over-the-counter (OTC) Natural Health Products (NHPs) to Canadian women.
Published by BMC Complementary Medicine and Therapies in March 2015, the study reviewed stores in Edmonton city belonging to nine different pharmacy chains. It found that out of 20 products, around 19 had Canada license numbers and were easily available to women.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Menopause Market Outlook will help companies and investors design strategic landscapes.
Dietary Supplements was the largest segment with a revenue share of 99.38% in 2024.
Horizon Databook has segmented the Canada menopause market based on hormonal, non-hormonal, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
There is an increase in awareness about dietary requirements, leading to a greater demand for them among older women. A study was conducted to assess the availability of Over-the-counter (OTC) Natural Health Products (NHPs) to Canadian women.
Published by BMC Complementary Medicine and Therapies in March 2015, the study reviewed stores in Edmonton city belonging to nine different pharmacy chains. It found that out of 20 products, around 19 had Canada license numbers and were easily available to women.
Canada Menopause Market treatment Outlook (Revenue, USD Million , 2018-2030)
Hormonal
Non-Hormonal
Dietary Supplements
Reasons to subscribe to Menopause Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Menopause Market Outlook databook
Our clientele includes a mix of Menopause Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Menopause Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada Menopause Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.